Nusano to Present at Piper Sandler Next-Gen RadioPharma Symposium

VALENCIA, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Next-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside chat-style presentation will highlight Nusano’s 2025 commercialization plans and provide an overview of how the company will leverage its proprietary technologies to make new supplies of rare and hard-to-produce radioisotopes available for medical and commercial markets.

To listen to the webcast, please contact your representative at Piper Sandler and request a link.

About Nusano
Nusano is a privately held physics company committed to bringing supply stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market, and to serving industrial and commercial markets dependent on reliable access to high quality radioisotopes for their products and services. Driven by the company’s proprietary ion source, the Nusano production platform will generate radioisotopes in volumes and varieties exceeding other production methods. Nusano’s breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. For more, please visit nusano.com.

Contacts:

• Media: Scott Larrivee, Nusano, 608-345-6629, scott.larrivee@nusano.com
• Investor Relations: Joyce Allaire, LifeSci Advisors, LLC, 212-915-2569, jallaire@lifesciadvisors.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.